GenMark Diagnostics Inc. (GNMK) Jumps 7.62% on January 14

Equities Staff |

GenMark Diagnostics Inc. (GNMK) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 7.62% to $7.42, representing a gain of $0.525 per share. Some 166,040 shares traded hands on 1,359 trades, compared with an average daily volume of 308,352 shares out of a total float of 42.44 million. The stock opened at $6.92 and traded with an intraday range of $7.49 to $6.81.

After today's gains, GenMark Diagnostics Inc. reached a market cap of $314.71 million. GenMark Diagnostics Inc. has had a trading range between $14.11 and $4.63 over the last year, and it had a 50-day SMA of $7.44 and a 200-day SMA of $8.94.

GenMark Diagnostics Inc is a molecular diagnostics company. The Company develops and commercializes its proprietary eSensor detection technology for the support of instruments and molecular tests.

GenMark Diagnostics Inc. is based out of Carlsbad, CA and has some 195 employees. Its CEO is Hany Massarany.

For a complete fundamental analysis analysis of GenMark Diagnostics Inc., check out’s Stock Valuation Analysis report for GNMK. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.